Oil breaks US$100, Wall Street retreats and bond yields rise, inflation is becoming the market’s biggest risk again Global markets are starting Thursday in a more defensive position. Brent crude has broken above US$100 a barrel , U.S. Treasury yields are pushing higher, and Wall Street fell for a third straight session as investors reassess whether central banks may need to keep tightening rather than easing. For Malaysian investors, the key chain today is increasingly clear: Oil → inflation → interest rates → bond yields → USD/MYR → Bursa valuations. 30-second market snapshot Market / Asset Latest 🇺🇸 S&P 500 7,636.36, -0.48% 🇺🇸 Dow Jones 52,380.66, -0.77% 🇺🇸 Nasdaq 26,253.34, -0.64% 🇲🇾 FBM KLCI 1,714.34, virtually flat 💵 USD/MYR ~4.06 🇺🇸 U.S. 10Y Treasury ~4.84% 🇺🇸 U.S. 2Y Treasury ~4.42% 🥇 Gold ~US$4,396/oz 🛢️ Brent crude US$101.21/bbl 🛢️ WTI crude US$96.05/bbl ₿ Bitcoin ~US$79,300 🇯🇵 Nikkei ~64,760, -0.6% this morning Brent jumped about 3.4% Wednesda...
Alpha IVF Group Bhd, through its subsidiary Alpha International (Shanghai) Medical Consulting Ltd, has launched a new office in Shanghai, China, to tap into the country's rapidly expanding in-vitro fertilization (IVF) market and bolster its regional presence.
Key Highlights:
New Shanghai Operations: The Shanghai office, operational since September 4, will act as a gateway for Chinese patients to access Alpha IVF’s fertility services and expertise. It will promote advanced fertility treatments, such as preimplantation genetic testing for aneuploidies (PGTA), an embryo screening technique for chromosomal abnormalities not currently available in China.
Focus on High Success Rates and Accessibility: The group aims to leverage its high IVF success rates and simplify the process for Chinese patients seeking treatment in Malaysia. The Shanghai office is expected to handle over 150 egg retrieval procedures annually, boosting the number of Chinese patients and enhancing the group's financial performance.
Strategic Expansion and Future Growth: Managing Director Datuk Dr. Colin Lee Soon Soo expressed optimism about growth opportunities in China, predicting that patient contributions would exceed pre-pandemic levels with the reopening of borders and the new office establishment. This move follows Alpha IVF’s recent international expansion into the Philippines through a joint venture, furthering its mission to make advanced fertility treatments more accessible.
Alpha IVF's entry into China marks its second international expansion after its initial public offering in March, reinforcing its strategy to grow its footprint in the global fertility market.
Comments
Post a Comment